BrightAccountsProduction v1.0.0 v1.0.0 2023-11-20 The company was not dormant during the period The company was trading for the entire period Unaudited Accounts FRS 105 Accounts The principal activity of the company is the provision of aesthetics procedures. 23 September 2025 1 NI705019 2024-12-31 NI705019 2023-11-19 NI705019 2023-11-20 2024-12-31 NI705019 uk-bus:PrivateLimitedCompanyLtd 2023-11-20 2024-12-31 NI705019 uk-curr:PoundSterling 2023-11-20 2024-12-31 NI705019 uk-bus:AbridgedAccounts 2023-11-20 2024-12-31 NI705019 uk-core:CapitalReserve 2024-12-31 NI705019 uk-core:ParentEntities 2023-11-20 2024-12-31 NI705019 2023-11-20 2024-12-31 NI705019 uk-bus:Director1 2023-11-20 2024-12-31 NI705019 uk-bus:AuditExempt-NoAccountantsReport 2023-11-20 2024-12-31 NI705019 uk-bus:Micro-entities 2023-11-20 2024-12-31 xbrli:pure iso4217:GBP xbrli:shares
 
 
 
 
 
 
 
 
 
 
 
Dr Cormac Lynch Medical Aesthetics Ltd
 
Unaudited Financial Statements
 
for the financial period from 20 November 2023 (date of incorporation) to 31 December 2024



Dr Cormac Lynch Medical Aesthetics Ltd
Company Registration Number: NI705019
STATEMENT OF FINANCIAL POSITION
as at 31 December 2024

    Dec 24
  £
 
Fixed Assets 32,400
  ─────────
Current assets 9,581
Creditors: amounts falling due within one year (41,346)
  ─────────
Net Current Liabilities (31,765)
  ─────────
Total Assets less Current Liabilities 635
  ─────────
Net Assets 635
  ═════════
 
Capital and Reserves 635
  ═════════
 
Notes to the Financial statements
   
1. General Information
 
Dr Cormac Lynch Medical Aesthetics Ltd is a company limited by shares incorporated and registered in Northern Ireland. The registered number of the company is NI705019. The registered office of the company is. The principal activity of the company is the provision of aesthetics procedures. The financial statements have been presented in Pound (£) which is also the functional currency of the company.

These financial statements cover the individual entity, Dr Cormac Lynch Medical Aesthetics Ltd, for the period ended 31st December 2024.
     
2. Employees
 
The average monthly number of employees, including director, during the financial period was
 
  Dec 24
  Number
 
Director 1
  ═════════
   
3. Parent company
 
The company regards DRCL Holdings Limited as its parent company.
 
   
4. Post-Balance Sheet Events
 
There have been no significant events affecting the company since the financial period-end.
     
For the financial period from 20 November 2023 (date of incorporation) to 31 December 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006.
 
The director confirms that the members have not required the company to obtain an audit of its financial statements for the financial period in question in accordance with section 476 of the Companies Act 2006.
 
The director acknowledges his responsibilities for ensuring that the company keeps accounting records which comply with section 386 and for preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of the financial period and of its profit and loss for the financial period in accordance with the requirements of sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.
 
These financial statements have been prepared in accordance with the provisions available to micro-entities in Part 15 of the Companies Act 2006 and delivered in accordance with the provisions applicable to companies subject to the small companies' regime.
 
The company has taken advantage of the exemption under section 444 not to file the Abridged Profit and Loss Account.
 
Approved by the Director on 23 September 2025 and signed by:
 
 
   
________________________________  
Dr Cormac Lynch  
Director